Skip to content

To Evaluate the efficacy of Arjuna Twaka Lepa in Vyanga.

Analytical and Clinical Study of Arjuna Twaka Lepa in Vyanga - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094444
Enrollment
40
Registered
2025-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

None listed

Sponsors

Rishikul Campus Haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having clinical sign and Symptoms of Vyanga (Melasma). Patients will be selected between the age ground of 20-50 years. Patients will be selected irrespective of gender and religion. Patients willingly participating in study trial. Chronicity less than 5 years.

Exclusion criteria

Exclusion criteria: 1 Patients of age below 20 years and above 50 years. 2 Patients having secondary systemic illness. 3 Melasma due to Tubercular therapy or malignant cases. 4 Any kind of heriditary skin disorder like Nevi ,freckles etc., 5 Patients taking OCP?s, pregnant women,lactating mothers.

Design outcomes

Primary

MeasureTime frame
Decrease in size and no. of lesion,decrease in darkness of pigmentation,Timepoint: The assessment will be done 3 times at an interval of 15 days till 45 days during the treatment

Secondary

MeasureTime frame
Decrease in hyperpigmentation lesions (Mandala)Timepoint: The assessment will be done 3 times at an interval of 15 days till 45 days during the

Countries

India

Contacts

Public ContactAyushi Uniyal

Rishikul Campus Haridwar

drdcschauhan@gmail.com9411175362

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026